Savvas Nicolaou

Savvas Nicolaou

Auto-generated profile, based on publicly available information

Savvas Nicolaou

Department of Radiology, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2019 in Academic Radiology
Verified
Journal Article
Closed access
BGBo Gong
Bo Gong
JNJames P. Nugent
James P. Nugent
WGWilliam Guest
William Guest
WPWilliam Parker
William Parker
PCPaul J. Chang
Paul J. Chang
SNSavvas Nicolaou
Savvas Nicolaou

1 December 2016 in Radiology
Verified
Journal Article
Closed access
PMPaul I. Mallinson
Paul I. Mallinson
TCTyler M. Coupal
Tyler M. Coupal
PMPatrick D. McLaughlin
Patrick D. McLaughlin
SNSavvas Nicolaou
Savvas Nicolaou
PMPeter L. Munk
Peter L. Munk
HOHugue A. Ouellette
Hugue A. Ouellette
The literature provides good evidence for bone marrow edema detection and metal artifact reduction, and some promising early results have been seen for tendon analysis, arthrography, and bone mineral density analysis. The principal advantages of dual-energy computed tomography (CT) over conventional CT in the musculoskeletal setting relate to the additional information provided regarding tissue composition, artifact reduction, and image optimization. This article discusses the manifestations of these in clinical practice—urate and bone marrow edema detection, metal artifact reduction, and tendon analysis, with potential in arthrography, bone densitometry, and metastases surveillance. The basic principles of dual-energy CT physics and scanner design will also be discussed.© RSNA, 2016

1 September 2012 in Annals of the Rheumatic Diseases
Verified
Journal Article
Closed access
PDF file
HCHyon K Choi
Hyon K Choi
LBLindsay C Burns
Lindsay C Burns
KSKamran Shojania
Kamran Shojania
NKNicole Koenig
Nicole Koenig
GRGraham Reid
Graham Reid
SNSavvas Nicolaou
Savvas Nicolaou
Objective The authors prospectively determined: (1) the specificity and sensitivity of dual energy CT (DECT) for gout; and (2) the interobserver and intraobserver reproducibility for DECT urate volume measurements. Methods Forty crystal-proven gout patients (17 tophaceous) and 40 controls with other arthritic conditions prospectively underwent DECT scans of all peripheral joints using a gout protocol that color-codes the composition of tissues. A blinded radiologist identified urate deposition to calculate specificity and sensitivity of DECT for gout. Inter-rater volumetric reproducibility was determined by two independent radiologists on 40 index tophi from the 17 tophaceous gout patients using automated software. Results The mean age of the 40 gout patients was 62 years, the mean gout duration was 13 years and 87% had a history of urate-lowering therapy (ULT). The specificity and sensitivity of DECT for gout were 0.93 (95% CI, 0.80 to 0.98) and 0.78 (0.62 to 0.89), respectively. When the authors excluded three gout cases with unreadable or incomplete scans, the sensitivity was 0.84 (95% CI, 0.68 to 0.94). The urate volumes of 40 index tophi ranged from 0.06 cm3 to 18.74 cm3 with a mean of 2.45 cm3. Interobserver and intraobserver intraclass correlation coefficients for DECT volume measurements were 1.00 (95% CI, 1.00 to 1.00) and 1.00 (95% CI, 1.00 to 1.00) with corresponding bias estimates (SD) of 0.01 (0.00) cm3 and 0.01 (0.03) cm3. Conclusions These prospective data indicate high reproducibility of DECT urate volume measures. The specificity was high, but sensitivity was more moderate, potentially due to frequent ULT use in our patients.

6 April 2015 in European Heart Journal - Cardiovascular Imaging
Verified
Journal Article
Open access
PDF file
JSJacqueline Saw
Jacqueline Saw
PFPeter Fahmy
Peter Fahmy
PDPeggy DeJong
Peggy DeJong
MLMathieu Lempereur
Mathieu Lempereur
RSRyan Spencer
Ryan Spencer
SNSavvas Nicolaou
Savvas Nicolaou
Left atrial appendage (LAA) device imaging after endovascular closure is important to assess for device thrombus, residual leak, positioning, surrounding structures, and pericardial effusion. Cardiac CT angiography (CCTA) is well suited to assess these non-invasively. We report our consecutive series of non-valvular atrial fibrillation patients who underwent CCTA post-LAA closure with Amplatzer Cardiac Plug (ACP), Amulet (second generation ACP), or WATCHMAN devices. Patients underwent CCTA typically 1–6 months post-implantation. Prospective cardiac-gated CCTA was performed with Toshiba 320-detector or Siemens 2nd generation 128-slice dual-source scanners, and images interpreted with VitreaWorkstation™. GFR <30 mL/min/1.73 m2 was an exclusion. We assessed for device thrombus, residual LAA leak, device embolization, position, pericardial effusion, optimal implantation, and device lobe dimensions. Forty-five patients underwent CCTA at median 97 days post-LAA closure (18 ACP, 9 Amulet, 18 WATCHMAN). Average age was 75.5 ± 8.9 years, mean CHADS2 score 3.1 ± 1.3, and CHADS-VASc score 4.9 ± 1.6. All had contraindications to oral anticoagulation. Post-procedure, 41 (91.1%) were discharged on DAPT. There was one device embolization (ACP, successfully retrieved percutaneously) and one thrombus (WATCHMAN, resolved with 3 months of warfarin). There were two pericardial effusions, both pre-existing and not requiring intervention. Residual leak (patency) was seen in 28/44 (63.6%), and the mechanisms of leak were readily identified by CCTA (off-axis device, gaps at orifice, or fabric leak). Mean follow-up was 1.2 ± 1.1year, with no death, stroke, or systemic embolism. CCTA appears to be a feasible alternative to transoesophageal echocardiography for post-LAA device surveillance to evaluate for device thrombus, residual leak, embolization, position, and pericardial effusion.

1 April 2010 in American Journal of Roentgenology
Verified
Journal Article
Closed access
SNSavvakis Nicolaou
Savvakis Nicolaou
CYCharlotte Jane Yong-Hing
Charlotte Jane Yong-Hing
SGSandro Galea-Soler
Sandro Galea-Soler
DHDaniel J. Hou
Daniel J. Hou
LLLuck Louis
Luck Louis
PMPeter Munk
Peter Munk
OBJECTIVE. Gout is the most common crystal deposition arthropathy currently diagnosed clinically and with arthrocentesis. Dual-energy CT is a promising new imaging technique offering potential new applications in a number of clinical areas.CONCLUSION. The ability of dual-energy CT to diagnose early gout and its use as a problem-solving tool is shown here. Diagnosis of subclinical gout could avert associated long-term complications, thereby reducing disease burden and improving overall quality of life.

1 November 2012 in American Journal of Roentgenology
Verified
Journal Article
Closed access
SNSavvakis Nicolaou
Savvakis Nicolaou
TLTeresa Liang
Teresa Liang
DMDarra T. Murphy
Darra T. Murphy
JKJeff R. Korzan
Jeff R. Korzan
HOHugue Ouellette
Hugue Ouellette
PMPeter Munk
Peter Munk
OBJECTIVE. Dual-energy CT (DECT) characterizes the chemical composition of material according to its differential x-ray attenuation at two different energy levels. Applications of DECT in musculoskeletal imaging include imaging of bone marrow edema, tendons, and ligaments and the use of monoenergetic techniques to minimize metal prosthesis beam-attenuating artifacts. CONCLUSION. The most validated application of DECT is undoubtedly its noninvasive and highly specific ability for confirming the presence of monosodium urate deposits in the assessment of gout.